SCRS Welcomes BioClinica As A New Global Impact Partner
Ellicott City, MD, September 8, 2016 – The Society for Clinical Research Sites (SCRS) announces Bioclinica as a new Global Impact Partner (GIP). Bioclinica is a provider of specialized technology-enabled services supporting clinical trials through a network of offices and research sites in the U.S., Europe, Asia, and South America.
As a GIP, Bioclinica will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council on setting and working toward strategic initiatives. In addition to executive level board participation, Bioclinica is also a Premier Sponsor of SCRS’ upcoming Global Site Solutions Summit in Boca Raton, Florida on October 13-16. Compass Research, a newly acquired site network of Bioclinica, is a finalist for SCRS’ 2016 Site Patient Recruitment Innovation Award (SPRIA).
“Bioclinica will be a tremendous partner in helping us achieve our goals,” said SCRS President, Christine Pierre. “They have consistently demonstrated strong commitment to improving trial design across their own global research site network, and we are pleased to welcome Bioclinica as a Global Impact Partner.”
Bioclinica President of Global Clinical Research, Elizabeth Thiele said, “We are delighted to partner with SCRS and other member companies where we have an opportunity to make a significant impact for the benefit of global clinical research sites everywhere.”
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 3,000 research sites in 49 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.
About Bioclinica
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process so sponsors can see key details, uncover hidden insights, and make better decisions. The Bioclinica Research Network offers an established, readily-available global network of investigator sites with access to select patient populations. Bioclinica serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe, Latin America and Asia. Learn more at www.bioclinica.com.
As a GIP, Bioclinica will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council on setting and working toward strategic initiatives. In addition to executive level board participation, Bioclinica is also a Premier Sponsor of SCRS’ upcoming Global Site Solutions Summit in Boca Raton, Florida on October 13-16. Compass Research, a newly acquired site network of Bioclinica, is a finalist for SCRS’ 2016 Site Patient Recruitment Innovation Award (SPRIA).
“Bioclinica will be a tremendous partner in helping us achieve our goals,” said SCRS President, Christine Pierre. “They have consistently demonstrated strong commitment to improving trial design across their own global research site network, and we are pleased to welcome Bioclinica as a Global Impact Partner.”
Bioclinica President of Global Clinical Research, Elizabeth Thiele said, “We are delighted to partner with SCRS and other member companies where we have an opportunity to make a significant impact for the benefit of global clinical research sites everywhere.”
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 3,000 research sites in 49 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.
About Bioclinica
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process so sponsors can see key details, uncover hidden insights, and make better decisions. The Bioclinica Research Network offers an established, readily-available global network of investigator sites with access to select patient populations. Bioclinica serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe, Latin America and Asia. Learn more at www.bioclinica.com.